Biopharma

STAT+: Fueled by pandemic frustrations, populist partie...

Fueled by pandemic frustrations, populist parties are embracing anti-vaccine fig...

Orphan designation: Arsenic trioxide Treatment of acute...

Orphan designation: Arsenic trioxide Treatment of acute promyelocytic leukaemia,...

Orphan designation: human anti-promyostatin monoclonal ...

Orphan designation: human anti-promyostatin monoclonal antibody (apitegromab) Tr...

Orphan designation: Lomitapide Treatment of familial ch...

Orphan designation: Lomitapide Treatment of familial chylomicronaemia, 17/12/201...

Orphan designation: Synthetic double-stranded siRNA oli...

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed aga...

Kisqali

Kisqali

FDA Approves Ctexli (chenodiol) for Cerebrotendinous Xa...

February 21, 2025 -- Today, the U.S. Food and Drug Administration approved Ctexl...

STAT+: What’s at stake in Friday’s court hearing on NIH...

A federal judge will hear arguments on whether to maintain a stay on a cap on NI...

STAT+: National Academies is altering pending reports t...

Words such as “health equity” are being replacing with vaguer terms, and 100 mem...

STAT+: Trump administration rehires some FDA employees ...

The Trump administration has started quietly rehiring some FDA employees just da...

STAT+: Dozens of attorneys general urge FDA to crack do...

More than three dozen attorneys general are urging the FDA to take “decisive act...

One Source Nutrition, Inc. Issues Voluntary Nationwide ...

Audience: Consumer Benton, Arkansas – February 20, 2025 –One Source Nutrition is...

FDA approves Roche's Evrysdi tablet as first and o...

Roche (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Admini...

Daily drug captures health benefits of high-altitude, l...

For the average person, living at high altitude - where oxygen is sparser than a...

AskBio Receives FDA Regenerative Medicine Advanced Ther...

AskBio Inc. (AskBio), a gene therapy company wholly owned and independently oper...

Common drug shows promise against rare type of heart di...

A research team co-led by scientists at the University of Arizona College of Med...

NUS Medicine pioneers ground-breaking technique to deli...

Scientists at the Yong Loo Lin School of Medicine, National University of Singap...

STAT+: Behind the scenes, Mass General Brigham fights D...

A fight over the future of cancer care is playing out in a behind-the-scenes bat...

More Than Two-Thirds of U.S. Counties Do Not Have a Gas...

FRIDAY, Feb. 21, 2025 -- About 69 percent of U.S. counties do not have a gastro...

Postpandemic Hospital Occupancy Up to 73.5 Percent, Spa...

FRIDAY, Feb. 21, 2025 -- Postpandemic hospital occupancy is higher than prepand...

Black Patients With Cancer Still Have Higher Mortality ...

FRIDAY, Feb. 21, 2025 -- Cancer mortality has decreased among Black Americans, ...

GSK struggles to convince market it can deliver on pipe...

US hedge fund shorts drugmaker as shares trade below price of a decade ago

Opinion: Is there an amyloid mafia? STAT readers weigh in

“Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ t...

Deputy director of FDA's CBER departs amid mass exodus ...

Celia Witten, M.D., Ph.D., is no longer deputy director of the FDA’s Center for ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.